BCG Vaccine-Associated Complications in Patients with PTEN Hamartoma Tumor Syndrome

J Clin Immunol. 2021 Oct;41(7):1701-1705. doi: 10.1007/s10875-021-01100-9. Epub 2021 Jul 16.

Authors

Henry Taylor¹, Dominik Aschenbrenner², Mike Thomson³, Hannah Chen², Holm H Uhlig^{2

4

5}

Affiliations

¹ Department of Surgery and Cancer, Imperial College London, London, UK. [email protected].
² Translational Gastroenterology Unit, University of Oxford, Oxford, UK.
³ Paediatric Gastroenterology, Sheffield Children's Hospital NHS Foundation Trust, Sheffield, UK.
⁴ Department of Paediatrics, University of Oxford, Oxford, UK.
⁵ Oxford NIHR Biomedical Research Centre, Oxford, UK.

PMID: 34269956
DOI: 10.1007/s10875-021-01100-9

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

BCG Vaccine / adverse effects*
Hamartoma Syndrome, Multiple*
Humans
Infant
Male
PTEN Phosphohydrolase / genetics

Substances

BCG Vaccine
PTEN Phosphohydrolase
PTEN protein, human

Grants and funding

DH_/Department of Health/United Kingdom